Article

CooperVision lobbies against contact lens legislation

Fairport, NY-CooperVision has launched a lobbying campaign instate legislatures throughout the United States to defeat proposalsthat would allow for the sale of contact lenses in what the companyconsiders poorly regulated and potentially unsafe distributionchannels.

Fairport, NY-CooperVision has launched a lobbying campaign in state legislatures throughout the United States to defeat proposals that would allow for the sale of contact lenses in what the company considers poorly regulated and potentially unsafe distribution channels.

This legislation is intended to prevent contact lens manufacturers from determining how best to distribute and sell their products, forcing them to sell their lenses to any mail-order company, Internet retailer, pharmacy, buying club, department store, and mass merchandise outlet that orders their product.

Now introduced in several states-including Alabama, Florida, Georgia, Indiana, Utah, and West Virginia-the legislation would subject non-compliant manufacturers and, in many cases, optometrists to civil or criminal penalties based on ambiguous and undefined standards such as "commercially reasonable" and "nondiscriminatory manner."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.